Category - Bonai News API

The Motley Fool
June 05, 2026
6 min read

When Will SpaceX, Anthropic, and OpenAI Join the S&P 500 Index?

S&P Dow Jones is considering altering its index admission policy to fast-track their entries.

Deadline
June 04, 2026
5 min read

Paramount Asks Judge To Dismiss Consumers’ Antitrust Lawsuit Seeking To Block Warner Bros. Discovery Merger

Paramount said that the plaintiffs, five consumers, have failed to state a plausible claim.

Homepage | Marquette University Law School
September 04, 2020
16 min read

A Unanimous Supreme Court Sides with the Generic – Marquette University Law School Faculty Blog

Just this morning, the Supreme Court issued its slip opinion on Hikma v. Amarin, the most recent “skinny-label” case, and it did so unanimously. Justice Jackson, writing for all nine, reversed the Federal Circuit and held that Amarin’s lawsuit against the generic manufacturer Hikma cannot survive a motion to dismiss. I had planned to spread this story across a short series (with the first one going live today — the life of an academic!), yet the Court’s timing collapsed it into one post. So let me take it from the top: how the generic-drug bargain works, how a fish-oil pill turned into a Supreme Court case, what the Justices made of it, and why this quiet dispute is one of the more consequential drug-pricing rulings in years.

WKRC
June 03, 2026
2 min read

'Do Not Drive' warning issued for thousands of Ford vehicles

A "Do Not Drive" warning was issued for thousands of Ford vehicles as part of a recall regarding an issue that could cause a "loss of vehicle control."

Motorsport.com: F1 News, MotoGP, NASCAR, Rallying and more
June 04, 2026
8 min read

Audi unveils Nuvolari supercar that could underpin its next GT3 contender

The brand-new Audi Nuvolari apparently shares its platform with the Lamborghini Temerario, which already has a GT3 version

Medical Marketing & Media
June 05, 2026
5 min read

Five things for pharma marketers to know for Friday, June 5, 2026

SCOTUS rules in favor of generics manufacturer in ‘skinny label’ case; Biotech deals amounted to $106 billion over 201 transactions in 2026; FDA data shows recalled acne products had shockingly high benzene levels.